comprehensive -WSS

comprehensive

author：fashion 2025-09-29 19:05:53 - browse：8

-- health policy coverage from STAT — Protestors outside America's Health Insurance Plans headquarters. Courtesy People's Action

WASHINGTON — Hundreds of activists rallied today outside of the headquarters of the country’s largest health insurance lobbying group to protest against restrictions to coverage in private Medicare plans.

The protesters were crammed into an already busy part of the city. A 10-minute walk from the Capitol building and a block off the National Mall, the headquarters for America’s Health Insurance Plans is located in a part of Washington that is crowded with tourists during the summer. The protesters, organized by a group called People’s Action, left messages on the sidewalk in chalk that included “You make us sick,” and “for-profit health ‘care’ killed my mom.”

People’s Action has worked with high-profile progressive lawmakers, including Sen. Elizabeth Warren (D-Mass.), to push for lower drug prices and Medicare for All.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Longer MASH drug regimen improved liver, Akero study finds

WSS

Readout Newsletter: BridgeBio, Akero, and human embryo models

Ancient Greek ideas underpin modern concepts of pregnancy

Streamlined flu vaccines recommended by FDA advisory panel

What we’ve learned from the Aduhelm mess

Vaccine advisory panel ACIP left half staffed by HHS

For Medicare Advantage, Democrats want stronger protections around AI

hotspot

comprehensive

focus

Bright Health sells Medicare Advantage business to Molina

Florida health officials providing scant details on measles cases

Alkermes shareholders re

Pregnant women don't need prenatal multivitamins, study concludes

Medical leaders decry Supreme Court decision on affirmative action

To avoid data mishandling cases, universities eye AI and other tools

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

explore

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

'Revelatory' study finds a smoking impact that remains after quitting

Microsoft's Peter Lee: Generative AI could help doctors be more human

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

He's 19 months old and has one of the world’s rarest diseases

What should King Charles tell the public about his cancer?

hotspot

Wikipedia

Wikipedia

explore